Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 1, 2013, Pages 142-147

  Kasturiratne, Anuradhani ^a   Weerasinghe, Sanjaya ^a   Dassanayake, Anuradha S ^a   Rajindrajith, Shaman ^a   de Silva, Arjuna P ^b   Kato, Norihiro ^b   Wickremasinghe, A Rajitha ^a   de Silva, H Janaka ^a  

^a UNIVERSITY OF KELANIYA   (Sri Lanka)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Clinical; Epidemiology; Fatty liver; Hepatology; Metabolism; Non alcoholic fatty liver disease

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SRI LANKA; URBAN POPULATION;

EID: 84871643501     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07264.x     Document Type: Article

References (20)

1. Tiniakos DG. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. Eur. J. Gastroenterol. Hepatol. 2010; 22: 643-650.
2. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J. Gastroenterol. 2008; 14: 185-192.
3. Yki-Järvinen H. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig. Dis. 2010; 28: 203-209.
4. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am. J. Gastroenterol. 2009; 104: 861-867.
5. Yamada T, Fukatsu M, Suzuki S, Wada T, Yoshida T, Joh T. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J. Gastroenterol. Hepatol. 2010; 25: 352-356.
6. Kim C-H, Park JY, Lee K-U, Kim J-H, Kim H-K. Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet. Med. 2008; 25: 476-481.
7. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F for Group Study D.E.S.I.R. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 2010; 10: 56.
8. Saadeh S, Younossi ZM, Remer EM etal. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
9. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh K. Asia-Pacific working party for NAFLD: how common is non-alcoholic fatty liver disease in the Asia-Pacific region and what are the local differences? J. Gastroenterol. Hepatol. 2007; 22: 788-793.
10. Dassanayake AS, Kasturiratne A, Rajindrajith S etal. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J. Gastroenterol. Hepatol. 2009; 24: 1284-1288.
11. Pinidiyapathirage MJ, Dassanayake AS, Rajindrajith S etal. Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka. BMC Res. Notes 2011; 4: 513.
12. Wijewardene K, Mohideen MR, Mendis S etal. Prevalence of hypertension, diabetes and obesity: baseline findings of a population based survey in four provinces in Sri Lanka. Ceylon Med. J. 2005; 50: 62-70.
13. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose-a review of diagnosis, clinical implications and management. Diab. Vasc. Dis. Res. 2005; 2: 9-15.
14. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. NIH Pub No 02-5215 Betesda, MD National Heart Lung and Blood Institute, National Institutes of Health, 2002.
15. Marchesini G, Bugianesi E, Forlani G etal. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923.
16. Mofrad P, Contos MJ, Haque M etal. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-1292.
17. Prati D, Taioli E, Zanella A etal. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 2002; 137: 1-10.
18. Kunde SS, Lazenby AJ, Clements RH, Abrams GA. Spectrum of NAFLD and diagnostic implications of the proposed new normal range of serum ALT in obese women. Hepatology 2005; 42: 650-656.
19. Bedogni G, Bellentani S, Miglioli L etal. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6: 33.
20. Kotronen A, Peltonen M, Hakkarainen A etal. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 2009; 137: 865-872.